Skystar Bio-Pharmaceutical CO (SKBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 18,353 | 14,240 | 6,833 | 9,625 | 15,992 |
| Cost of Goods | 9,590 | 7,881 | 4,009 | 4,906 | 7,779 |
| Gross Profit | 8,763 | 6,359 | 2,823 | 4,720 | 8,214 |
| Operating Expenses | 3,953 | 3,872 | 1,660 | 2,967 | 4,255 |
| Operating Income | 5,400 | 3,368 | 1,172 | 2,659 | 4,738 |
| Interest Expense | 252 | 137 | 76 | 47 | 155 |
| Other Income | 475 | 262 | 309 | 322 | -67 |
| Pre-tax Income | 5,622 | 3,493 | 1,406 | 2,934 | 4,516 |
| Income Tax | 713 | 682 | 430 | 601 | 782 |
| Net Income Continuous | 4,910 | 2,811 | 976 | 2,332 | 3,734 |
| Net Income | $4,910 | $2,811 | $976 | $2,332 | $3,734 |
| EPS Basic Total Ops | 0.58 | 0.37 | 0.13 | 0.31 | 0.49 |
| EPS Basic Continuous Ops | 0.58 | 0.36 | 0.13 | 0.30 | 0.49 |
| EPS Diluted Total Ops | 0.57 | 0.36 | 0.13 | 0.30 | 0.49 |
| EPS Diluted Continuous Ops | 0.57 | 0.36 | 0.13 | 0.30 | 0.49 |
| EBITDA(a) | $5,840 | $3,901 | $1,635 | $3,101 | $5,256 |